ReP USP - Resultado da busca

Artigo de periodico
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry (2019)
Jerjes-sanchez, Carlos; Corbalan, Ramon; Barretto, Antonio Carlos Pereira; Luciardi, Hector L; Allu, Jagan; Illingworth, Laura; Pieper, Karen S; Kayani, Gloria
Source: Clinical cardiology. Unidade: FM
Subjects: ACIDENTE VASCULAR CEREBRAL, FIBRILAÇÃO ATRIAL, ANTICOAGULANTES, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JERJES-SANCHEZ, Carlos et al. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry. Clinical cardiology, v. 42, n. 5, p. 553-560, 2019Tradução . . Disponível em: https://doi.org/10.1002/clc.23176. Acesso em: 31 out. 2024.
APA
Jerjes-sanchez, C., Corbalan, R., Barretto, A. C. P., Luciardi, H. L., Allu, J., Illingworth, L., et al. (2019). Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry. Clinical cardiology, 42( 5), 553-560. doi:10.1002/clc.23176
NLM
Jerjes-sanchez C, Corbalan R, Barretto ACP, Luciardi HL, Allu J, Illingworth L, Pieper KS, Kayani G. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry [Internet]. Clinical cardiology. 2019 ; 42( 5): 553-560.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/clc.23176
Vancouver
Jerjes-sanchez C, Corbalan R, Barretto ACP, Luciardi HL, Allu J, Illingworth L, Pieper KS, Kayani G. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry [Internet]. Clinical cardiology. 2019 ; 42( 5): 553-560.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/clc.23176
Artigo de periodico
Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation a report from the GARFIELD-AF registry (2019)
Corbalan, Ramon; Bassand, Jean-Pierre; Illingworth, Laura; Ambrosio, Giuseppe; Camm, A. John; Fitzmaurice, David A; Fox, Keith A. A; Goldhaber, Samuel Z; Goto, Shinya; Barretto, Antonio Carlos Pereira
Source: Jama cardiology. Unidade: FM
Subjects: CARDIOPATIAS, FIBRILAÇÃO ATRIAL, INSUFICIÊNCIA CARDÍACA CONGESTIVA, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORBALAN, Ramon et al. Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation a report from the GARFIELD-AF registry. Jama cardiology, v. 4, n. 6, p. 526-548, 2019Tradução . . Disponível em: https://doi.org/10.1001/jamacardio.2018.4729. Acesso em: 31 out. 2024.
APA
Corbalan, R., Bassand, J. -P., Illingworth, L., Ambrosio, G., Camm, A. J., Fitzmaurice, D. A., et al. (2019). Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation a report from the GARFIELD-AF registry. Jama cardiology, 4( 6), 526-548. doi:10.1001/jamacardio.2018.4729
NLM
Corbalan R, Bassand J-P, Illingworth L, Ambrosio G, Camm AJ, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Barretto ACP. Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation a report from the GARFIELD-AF registry [Internet]. Jama cardiology. 2019 ; 4( 6): 526-548.[citado 2024 out. 31 ] Available from: https://doi.org/10.1001/jamacardio.2018.4729
Vancouver
Corbalan R, Bassand J-P, Illingworth L, Ambrosio G, Camm AJ, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Barretto ACP. Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation a report from the GARFIELD-AF registry [Internet]. Jama cardiology. 2019 ; 4( 6): 526-548.[citado 2024 out. 31 ] Available from: https://doi.org/10.1001/jamacardio.2018.4729
Artigo de periodico
Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial (2018)
Corbalan, Ramon; Nicolau, Jose Carlos
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 31 out. 2024.
APA
Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
NLM
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Vancouver
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Artigo de periodico
Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial (2015)
Udell, Jacob A.; Bhatt, Deepak L.; Braunwald, Eugene; Cavender, Matthew A.; Mosenzon, Ofri; Steg, Gabriel; Davidson, Jaime A.; Nicolau, Jose C.; Corbalan, Ramon; Hirshberg, Boaz; Frederich, Robert; Im, KyungAh; Umez-Eronini, Amarachi A.; He, Ping; McGuire, Darren K.; Leiter, Lawrence A.; Raz, Itamar; Scirica, Benjamin M.
Source: Diabetes Care. Unidade: FM
Subjects: DIABTES MELLITUS (COMPLICAÇÕES), FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, INIBIDORES DE ENZIMAS, NEOPLASIAS (ETIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UDELL, Jacob A. et al. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care, v. 38, n. 4, p. 696-705, 2015Tradução . . Disponível em: https://doi.org/10.2337/dc14-1850. Acesso em: 31 out. 2024.
APA
Udell, J. A., Bhatt, D. L., Braunwald, E., Cavender, M. A., Mosenzon, O., Steg, G., et al. (2015). Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care, 38( 4), 696-705. doi:10.2337/dc14-1850
NLM
Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg G, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im KA, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial [Internet]. Diabetes Care. 2015 ; 38( 4): 696-705.[citado 2024 out. 31 ] Available from: https://doi.org/10.2337/dc14-1850
Vancouver
Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg G, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im KA, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial [Internet]. Diabetes Care. 2015 ; 38( 4): 696-705.[citado 2024 out. 31 ] Available from: https://doi.org/10.2337/dc14-1850
Artigo de periodico
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease (2014)
White, Harvey D.; Held, Claes; Stewart, Ralph; Tarka, Elizabeth; Brown, Rebekkah; Davies, Richard Y.; Budaj, Andrzej; Harrington, Robert A.; Steg, P. Gabriel; Ardissino, Diego; Armstrong, Paul W.; Avezum, Alvaro; Aylward, Philip E.; Bryce, Alfonso; Chen, Hong; Chen, Ming-Fong; Corbalan, Ramon; Dalby, Anthony J.; Danchin, Nicolas; De Winter, Robbert J.; Denchev, Stefan; Diaz, Rafael; Elisaf, Moses; Flather, Marcus D.; Goudev, Assen R.; Granger, Christopher B.; Grinfeld, Liliana; Hochman, Judith S.; Husted, Steen; Kim, Hyo-Soo; Koenig, Wolfgang; Linhart, Ales; Lonn, Eva; López-Sendón, José; Manolis, Athanasios J.; Mohler III, Emile R.; Nicolau, José C.; Pais, Prem; Parkhomenko, Alexander; Pedersen, Terje R.; Pella, Daniel; Ramos-Corrales, Marco A.; Ruda, Mikhail; Sereg, Mátyás; Siddique, Saulat; Sinnaeve, Peter; Smith, Peter; Sritara, Piyamitr; Swart, Henk P.; Sy, Rody G.; Teramoto, Tamio; Tse, Hung-Fat; Watson, David; Weaver, W. Douglas; Weiss, Robert; Viigimaa, Margus; Vinereanu, Dragos; Zhu, Junren; Cannon, Christopher P.; Wallentin, Lars
Source: The New England Journal of Medicine. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE), ARTERIOSCLEROSE CORONÁRIA, FOSFOLIPASES A, REAÇÃO EM CADEIA POR POLIMERASE, BIOLOGIA MOLECULAR, ANÁLISE SEQUENCIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WHITE, Harvey D. et al. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, v. 370, n. 18, p. 1702-1711, 2014Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1315878. Acesso em: 31 out. 2024.
APA
White, H. D., Held, C., Stewart, R., Tarka, E., Brown, R., Davies, R. Y., et al. (2014). Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, 370( 18), 1702-1711. doi:10.1056/NEJMoa1315878
NLM
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.[citado 2024 out. 31 ] Available from: https://doi.org/10.1056/NEJMoa1315878
Vancouver
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.[citado 2024 out. 31 ] Available from: https://doi.org/10.1056/NEJMoa1315878
Artigo de periodico
Cardiovascular clinical research in South America (2013)
Nicolau, José C.; Corbalan, Ramon; Diaz, Rafael; Bahit, Cecilia; Armstrong, Paul W.; Granger, Christopher B.; Lopes, Renato D.
Source: American Heart Journal. Unidade: FM
Subjects: PESQUISA BIOMÉDICA, DOENÇAS CARDIOVASCULARES (DIAGNÓSTICO), AMÉRICA DO SUL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NICOLAU, José C. et al. Cardiovascular clinical research in South America. American Heart Journal, v. 165, n. 6, p. 848-853, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2013.02.004. Acesso em: 31 out. 2024.
APA
Nicolau, J. C., Corbalan, R., Diaz, R., Bahit, C., Armstrong, P. W., Granger, C. B., & Lopes, R. D. (2013). Cardiovascular clinical research in South America. American Heart Journal, 165( 6), 848-853. doi:10.1016/j.ahj.2013.02.004
NLM
Nicolau JC, Corbalan R, Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD. Cardiovascular clinical research in South America [Internet]. American Heart Journal. 2013 ; 165( 6): 848-853.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ahj.2013.02.004
Vancouver
Nicolau JC, Corbalan R, Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD. Cardiovascular clinical research in South America [Internet]. American Heart Journal. 2013 ; 165( 6): 848-853.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ahj.2013.02.004
Artigo de periodico
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization (2012)
Roe, Matthew T; Armstrong, Paul W; Fox, Keith A. A; White, Harvey; Prabhakaran, Dorairaj; Goodman, Shaun G; Cornel, Jan H; Bhatt, Deepak L; Clemmensen, Peter; Martinez, Felipe; Ardissino, Diego; Nicolau, Jose Carlos; Boden, William E; Gurbel, Paul A; Ruzyllo, Witold; Dalby, Anthony J; McGuire, Darren K; Leiva-Pons, Jose L; Parkhomenko, Alexander; Gottlieb, Shmuel; Topacio, Gracita O; Hamm, Christian; Pavlides, Gregory; Goudev, Assen R; Oto, Ali; Tseng, Chuen-Den; Merkely, Bela; Gasparovic, Vladimir; Corbalan, Ramon; Cinteză, Mircea; McLendon, R. Craig; Winters, Kenneth J; Brown, Eileen B; Lokhnygina, Yuliya; Aylward, Philip E; Huber, Kurt; Hochman, Judith S; Ohman, E. Magnus; Marin Neto, Jose Antonio
Source: The New England Journal of Medicine. Unidades: FMRP, FM
Assunto: REVASCULARIZAÇÃO MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROE, Matthew T et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. The New England Journal of Medicine, v. 367, n. 14, p. 1297-1309, 2012Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1205512. Acesso em: 31 out. 2024.
APA
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H., Prabhakaran, D., Goodman, S. G., et al. (2012). Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. The New England Journal of Medicine, 367( 14), 1297-1309. doi:10.1056/NEJMoa1205512
NLM
Roe MT, Armstrong PW, Fox KAA, White H, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng C-D, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM, Marin Neto JA. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization [Internet]. The New England Journal of Medicine. 2012 ; 367( 14): 1297-1309.[citado 2024 out. 31 ] Available from: https://doi.org/10.1056/NEJMoa1205512
Vancouver
Roe MT, Armstrong PW, Fox KAA, White H, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng C-D, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM, Marin Neto JA. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization [Internet]. The New England Journal of Medicine. 2012 ; 367( 14): 1297-1309.[citado 2024 out. 31 ] Available from: https://doi.org/10.1056/NEJMoa1205512
Trabalho de evento-resumo periodico
The EPHESUS trial: effect of eplerenome in patients eith a baseline history of hypertension (2003)
Pitt, Bertram; Krum, Henry; Nicolau, Jose Carlos; Cardoso, Silva; Parkhomenko, Alexander; Aschermann, Michael; Corbalan, Ramon; Zannad, Faiez; Bittman, Richard; Kleiman, Jay
Source: Circulation. Conference titles: Abstracts From Scientific Sessions. Unidade: FM
Assunto: HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PITT, Bertram et al. The EPHESUS trial: effect of eplerenome in patients eith a baseline history of hypertension. Circulation. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2003
APA
Pitt, B., Krum, H., Nicolau, J. C., Cardoso, S., Parkhomenko, A., Aschermann, M., et al. (2003). The EPHESUS trial: effect of eplerenome in patients eith a baseline history of hypertension. Circulation. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.
NLM
Pitt B, Krum H, Nicolau JC, Cardoso S, Parkhomenko A, Aschermann M, Corbalan R, Zannad F, Bittman R, Kleiman J. The EPHESUS trial: effect of eplerenome in patients eith a baseline history of hypertension. Circulation. 2003 ; 108( 17): IV-599.[citado 2024 out. 31 ]
Vancouver
Pitt B, Krum H, Nicolau JC, Cardoso S, Parkhomenko A, Aschermann M, Corbalan R, Zannad F, Bittman R, Kleiman J. The EPHESUS trial: effect of eplerenome in patients eith a baseline history of hypertension. Circulation. 2003 ; 108( 17): IV-599.[citado 2024 out. 31 ]

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation